Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details)

v3.22.2.2
SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) - shares
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 3,679,793 3,384,984
Stock Options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 1,149,701 854,892
Stock Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 2,530,092 2,530,092